Exhibit 99.2
This Statement on Form 4 is filed by: (i) John D. Shulman, (ii) JCP III SM AIV, L.P., (iii) METP Holdings, LLC, (iv) Juggernaut Partners III GP, L.P., and (v) Juggernaut Partners III GP, Ltd.
Name of Designated Filer: John D. Shulman
Date of Event Requiring Statement: November 29, 2021
Issuer Name and Ticker or Trading Symbol: Petros Pharmaceuticals, Inc. [PTPI]
John D. Shulman | ||
/s/ John D. Shulman | ||
METP Holdings, LLC | |||
By: | Juggernaut Partners III GP, L.P., | ||
its general partner | |||
By: Juggernaut Partners III GP, Ltd. its general partner | |||
By: | /s/ John D. Shulman | ||
Name: John D. Shulman Title: Director |
JCP III SM AIV, L.P. | |||
By: | Juggernaut Partners III GP, L.P., | ||
its general partner | |||
By: Juggernaut Partners III GP, Ltd. its general partner | |||
By: | /s/ John D. Shulman | ||
Name: John D. Shulman Title: Director | |||
Juggernaut Partners III GP, L.P. | |||
By: | Juggernaut Partners III GP, Ltd. | ||
its general partner | |||
By: | /s/ John D. Shulman | ||
Name: | John D. Shulman | ||
Title: | Director | ||
Juggernaut Partners III GP, Ltd. | ||
By: | /s/ John D. Shulman | |
Name: | John D. Shulman | |
Title: | Director |